[
  {
    "ts": null,
    "headline": "GE HealthCare Technologies Inc. stock falls Wednesday, underperforms market",
    "summary": "GE HealthCare Technologies Inc. stock falls Wednesday, underperforms market",
    "url": "https://finnhub.io/api/news?id=1c7776db341a37c2534c03b0b18c7d3e59cb033526351e90c023e8eaad4de7df",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747241760,
      "headline": "GE HealthCare Technologies Inc. stock falls Wednesday, underperforms market",
      "id": 134478657,
      "image": "",
      "related": "GEHC",
      "source": "MarketWatch",
      "summary": "GE HealthCare Technologies Inc. stock falls Wednesday, underperforms market",
      "url": "https://finnhub.io/api/news?id=1c7776db341a37c2534c03b0b18c7d3e59cb033526351e90c023e8eaad4de7df"
    }
  },
  {
    "ts": null,
    "headline": "GE HealthCare gets FDA approval for Optison ultrasound enhancing agent",
    "summary": "GE HealthCare (GEHC) announced the FDA has approved a pediatric indication for its Optison ultrasound enhancing agent. This approval will help improve the clarity of echocardiograms for diagnosing heart conditions in pediatric patients, enhancing the assessment of ventricular function. Optison, the only PEG-free UEA available in the U.S., was first approved for adult use in 1997. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See I",
    "url": "https://finnhub.io/api/news?id=e48923e30db5aa8e6a06662ae5799bda45632207fed9dc44502406659c24cf81",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747228441,
      "headline": "GE HealthCare gets FDA approval for Optison ultrasound enhancing agent",
      "id": 134461383,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GEHC",
      "source": "Yahoo",
      "summary": "GE HealthCare (GEHC) announced the FDA has approved a pediatric indication for its Optison ultrasound enhancing agent. This approval will help improve the clarity of echocardiograms for diagnosing heart conditions in pediatric patients, enhancing the assessment of ventricular function. Optison, the only PEG-free UEA available in the U.S., was first approved for adult use in 1997. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See I",
      "url": "https://finnhub.io/api/news?id=e48923e30db5aa8e6a06662ae5799bda45632207fed9dc44502406659c24cf81"
    }
  },
  {
    "ts": null,
    "headline": "IXJ: Healthcare Sector Dashboard For May",
    "summary": "This article provides a top-down analysis of the healthcare sector using value, quality, and momentum metrics. Read the full analysis here on Seeking Alpha, updated for May 2025.",
    "url": "https://finnhub.io/api/news?id=6034d561f5dd4a27632eead6ab25b5a039e4bdb6720041cd8cd9e718132da992",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747223425,
      "headline": "IXJ: Healthcare Sector Dashboard For May",
      "id": 134437816,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1356518831/image_1356518831.jpg?io=getty-c-w1536",
      "related": "GEHC",
      "source": "SeekingAlpha",
      "summary": "This article provides a top-down analysis of the healthcare sector using value, quality, and momentum metrics. Read the full analysis here on Seeking Alpha, updated for May 2025.",
      "url": "https://finnhub.io/api/news?id=6034d561f5dd4a27632eead6ab25b5a039e4bdb6720041cd8cd9e718132da992"
    }
  }
]